Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-po… Read more
Teva Pharmaceutical Industries Limited (TEVJF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.193x
Based on the latest financial reports, Teva Pharmaceutical Industries Limited (TEVJF) has a cash flow conversion efficiency ratio of 0.193x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.53 Billion) by net assets ($7.92 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Teva Pharmaceutical Industries Limited - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Teva Pharmaceutical Industries Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Teva Pharmaceutical Industries Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Teva Pharmaceutical Industries Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
F5 Networks Inc
NASDAQ:FFIV
|
0.045x |
|
Emera Incorporated
NYSE:EMA
|
0.016x |
|
H4W0
F:H4W0
|
N/A |
|
SGS SA
PINK:SGSOF
|
0.788x |
|
Arm Holdings plc
F:O9T
|
0.066x |
|
W. R. Berkley Corp
NYSE:WRB
|
0.116x |
|
FinecoBank Banca Fineco S.p.A
PINK:FNBKY
|
0.430x |
|
RBC Bearings Incorporated
NYSE:RBC
|
0.037x |
Annual Cash Flow Conversion Efficiency for Teva Pharmaceutical Industries Limited (1991–2025)
The table below shows the annual cash flow conversion efficiency of Teva Pharmaceutical Industries Limited from 1991 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.92 Billion | $3.10 Billion | 0.392x | +79.59% |
| 2024-12-31 | $5.72 Billion | $1.25 Billion | 0.218x | +29.50% |
| 2023-12-31 | $8.13 Billion | $1.37 Billion | 0.168x | -7.98% |
| 2022-12-31 | $8.69 Billion | $1.59 Billion | 0.183x | +157.78% |
| 2021-12-31 | $11.24 Billion | $798.00 Million | 0.071x | -35.44% |
| 2020-12-31 | $11.06 Billion | $1.22 Billion | 0.110x | +207.80% |
| 2019-12-31 | $15.06 Billion | $538.00 Million | 0.036x | -76.94% |
| 2018-12-31 | $15.79 Billion | $2.45 Billion | 0.155x | -17.22% |
| 2017-12-31 | $18.75 Billion | $3.51 Billion | 0.187x | +25.30% |
| 2016-12-31 | $34.99 Billion | $5.22 Billion | 0.149x | -19.37% |
| 2015-12-31 | $29.93 Billion | $5.54 Billion | 0.185x | -15.64% |
| 2014-12-31 | $23.36 Billion | $5.13 Billion | 0.220x | +53.51% |
| 2013-12-31 | $22.64 Billion | $3.24 Billion | 0.143x | -28.48% |
| 2012-12-31 | $22.87 Billion | $4.57 Billion | 0.200x | +8.06% |
| 2011-12-31 | $22.34 Billion | $4.13 Billion | 0.185x | -1.57% |
| 2010-12-31 | $22.00 Billion | $4.14 Billion | 0.188x | +7.33% |
| 2009-12-31 | $19.26 Billion | $3.37 Billion | 0.175x | -11.32% |
| 2008-12-31 | $16.36 Billion | $3.23 Billion | 0.197x | +49.89% |
| 2007-12-31 | $13.76 Billion | $1.81 Billion | 0.132x | -28.44% |
| 2006-12-31 | $11.18 Billion | $2.06 Billion | 0.184x | -18.68% |
| 2005-12-31 | $6.05 Billion | $1.37 Billion | 0.226x | -2.09% |
| 2004-12-31 | $5.40 Billion | $1.25 Billion | 0.231x | +21.65% |
| 2003-12-31 | $3.30 Billion | $626.60 Million | 0.190x | -1.41% |
| 2002-12-31 | $1.83 Billion | $353.70 Million | 0.193x | -2.38% |
| 2001-12-31 | $1.38 Billion | $273.15 Million | 0.198x | +37.51% |
| 2000-12-31 | $1.15 Billion | $165.63 Million | 0.144x | -30.58% |
| 1999-12-31 | $742.30 Million | $153.61 Million | 0.207x | +94.44% |
| 1998-12-31 | $659.60 Million | $70.20 Million | 0.106x | -66.31% |
| 1997-12-31 | $612.80 Million | $193.60 Million | 0.316x | +2586.53% |
| 1996-12-31 | $535.20 Million | $-6.80 Million | -0.013x | -104.91% |
| 1995-12-31 | $407.60 Million | $105.40 Million | 0.259x | +131.78% |
| 1994-12-31 | $342.40 Million | $38.20 Million | 0.112x | -20.72% |
| 1993-12-31 | $267.90 Million | $37.70 Million | 0.141x | +11.33% |
| 1992-12-31 | $223.10 Million | $28.20 Million | 0.126x | +154.19% |
| 1991-12-31 | $183.00 Million | $9.10 Million | 0.050x | -- |